Ticker Details
MIMEDX GROUP INC MiMedx Group Inc is a developer, manufacturer and marketer of patent-protected regenerative biomaterial products and bioimplants processed from human amniotic membrane.
IPO Date:	March 1, 2008
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$539.18M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.18 | 2.45%
Avg Daily Range (30 D):	$0.10 | 2.74%
Avg Daily Range (90 D):	$0.08 | 1.83%

Institutional Daily Volume
Avg Daily Volume:	.71M
Avg Daily Volume (30 D):	1.49M
Avg Daily Volume (90 D):	1.07M

Trade Size
Avg Trade Size (Sh.):	143
Avg Trade Size (Sh.) (30 D):	136
Avg Trade Size (Sh.) (90 D):	112

Institutional Trades
Total Institutional Trades:	2,155
Avg Institutional Trade:	$1.38M
Avg Institutional Trade (30 D):	$.85M
Avg Institutional Trade (90 D):	$1.05M
Avg Institutional Trade Volume:	.17M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.45M
Avg Closing Trade (30 D):	$.85M
Avg Closing Trade (90 D):	$.95M
Avg Closing Volume:	178.71K

News

Feb 17, 2026 @ 1:00 PM MIMEDX to Host Fourth Quarter and Full Year 2025 O... Source: Na

Feb 2, 2026 @ 1:00 PM MIMEDX Celebrates 15 Year Anniversary of EPIFIXÂÂ... Source: Mimedx Group, Inc.

Oct 15, 2025 @ 12:00 PM MIMEDX to Host Third Quarter 2025 Operating and Fi... Source: Matt Notarianni

Sep 3, 2025 @ 12:00 PM MIMEDX to Sponsor and Attend Symposium on Advanced... Source: Matt Notarianni

Feb 12, 2025 @ 12:00 PM MediWound Initiates the VALUE Global Phase III Piv... Source: N/A

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$.22	$-.07
Diluted EPS	$.2	$-.07
Revenue	$389.42M	$58.99M
Gross Profit	$315.59M	$41.62M
Net Income / Loss	$30.7M	$-10.86M
Operating Income / Loss	$39.59M	$-16.05M
Cost of Revenue	$73.82M	$17.37M
Net Cash Flow	$53.34M	$-6.35M
PE Ratio

Splits
Apr 02, 2008	11:34